Spatiotemporal Delivery of miRNA Anatgomir for Promoting Vascular Self-Assembly

miRNA Anatgomir 的时空传递促进血管自组装

基本信息

  • 批准号:
    8322816
  • 负责人:
  • 金额:
    $ 24.91万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-08-19 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Previous work has demonstrated that well differentiated human endothelial cells (ECs) will self assemble into vascular conduits in protein gels both in vitro and in vivo after implantation into immunodeficient mouse hosts. Vessel maturation in grafts containing only EC requires recruitment of host mural cells, such as vascular smooth muscle cells or pericytes (PCs). The maturation of vessels is accelerated and enhanced when ECs are co-implanted with human PCs. Vessel self assembly can also be enhanced by sustained delivery of pro- angiogenic proteins that act on ECs or PCs, especially when an EC-directed agent, vascular endothelial growth factor (VEGF), is combined with a PC-directed agent, monocyte chemotactic protein -1 (MCP-1). However, vessel self-assembly and maturation still appears too slow to optimize parenchymal cell survival, requiring at least 10 days. The actions of pro-angiogenic proteins may be augmented or limited by positive and negative feedback loops, respectively, within the target cells that involve microRNAs (miRNAs). miRNAs are short, non-coding RNAs that regulate a variety of development processes by reducing specific mRNA half lives or translation. A single miRNA can reduce the expression of multiple genes often in the same pathway. The effects of miRNAs can be inhibited by complementary short RNA sequences referred to as antagomirs. Antagomirs act in a cell-specific manner when the miRNA is expressed in a cell specific manner. This project tests the hypothesis that controlled delivery of an antagomir can enhance the therapeutic benefits of angiogenic proteins such as VEGF in vascular self-assembly. This hypothesis will be tested through two specific aims. In Aim 1, polymer nanoparticles (NP) will be used to find the optimal approaches for providing spatial and temporal control over miRNA and antagomir delivery to the cytoplasm of ECs in 3D culture. In Aim 2, these NP delivery systems will be tested for their ability to control the spatial and temporal delivery of antagomirs to miR-17/20-which is known to augment the effects of VEGF-to 3D cell cultures produced by suspending ECs and PCs in gels of collagen and fibronectin. (End of Abstract)
描述(由申请人提供): 以前的工作已经证明,分化良好的人内皮细胞(EC)将自组装成血管管道的蛋白质凝胶在体外和体内植入免疫缺陷小鼠宿主后。仅含有EC的移植物中的血管成熟需要募集宿主壁细胞,例如血管平滑肌细胞或周细胞(PC)。当EC与人PC共植入时,血管的成熟加速并增强。血管自组装也可以通过持续递送作用于EC或PC的促血管生成蛋白来增强,特别是当EC导向剂血管内皮生长因子(VEGF)与PC导向剂单核细胞趋化蛋白-1(MCP-1)组合时。然而,血管自组装和成熟仍然显得太慢,无法优化实质细胞存活,需要至少10天。促血管生成蛋白的作用可以分别通过靶细胞内涉及microRNA(miRNA)的正反馈环和负反馈环来增强或限制。miRNA是短的非编码RNA,通过减少特定mRNA的半衰期或翻译来调节多种发育过程。单个miRNA可以减少通常在同一途径中的多个基因的表达。miRNAs的作用可以被称为miRNAs的互补短RNA序列抑制。当miRNA以细胞特异性方式表达时,拮抗剂以细胞特异性方式起作用。该项目测试了一种假设,即控制递送Escheromir可以增强血管生成蛋白(如VEGF)在血管自组装中的治疗益处。这一假设将通过两个具体目标进行检验。在目标1中,聚合物纳米颗粒(NP)将用于找到在3D培养中提供对miRNA和Eschomir递送至EC细胞质的空间和时间控制的最佳方法。在目标2中,将测试这些NP递送系统控制将西莫司递送至miR-17/20的空间和时间递送的能力-已知其增强VEGF对通过将EC和PC悬浮在胶原蛋白和纤连蛋白的凝胶中产生的3D细胞培养物的作用。 (End摘要)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JORDAN S POBER其他文献

JORDAN S POBER的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JORDAN S POBER', 18)}}的其他基金

Ex Vivo Nanoparticle Drug Delivery Targeted to Human Allograft Endothelium
针对人同种异体移植物内皮的体外纳米颗粒药物输送
  • 批准号:
    10783379
  • 财政年份:
    2023
  • 资助金额:
    $ 24.91万
  • 项目类别:
Assessment of immunogenicity and antigenicity of different human cell types in natural and 3D-printed allografts
评估天然和 3D 打印同种异体移植物中不同人类细胞类型的免疫原性和抗原性
  • 批准号:
    10353416
  • 财政年份:
    2021
  • 资助金额:
    $ 24.91万
  • 项目类别:
Assessment of immunogenicity and antigenicity of different human cell types in natural and 3D-printed allografts
评估天然和 3D 打印同种异体移植物中不同人类细胞类型的免疫原性和抗原性
  • 批准号:
    10194232
  • 财政年份:
    2021
  • 资助金额:
    $ 24.91万
  • 项目类别:
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Renal Allograft Endothelium
针对人肾同种异体移植物内皮的体外纳米颗粒药物输送
  • 批准号:
    10197784
  • 财政年份:
    2017
  • 资助金额:
    $ 24.91万
  • 项目类别:
Ex Vivo Nanoparticle Drug Delivery Targeted to Human Renal Allograft Endothelium
针对人肾同种异体移植物内皮的体外纳米颗粒药物输送
  • 批准号:
    10155842
  • 财政年份:
    2017
  • 资助金额:
    $ 24.91万
  • 项目类别:
Optimizing Therapeutic Revascularization by Endothelial Cell Transplantation
通过内皮细胞移植优化治疗性血运重建
  • 批准号:
    9516109
  • 财政年份:
    2017
  • 资助金额:
    $ 24.91万
  • 项目类别:
Targeting Nanoparticles for Drug Delivery to Renal Graft Endothelium during Ex Vivo Normothermic Perfusion
体外常温灌注期间靶向纳米颗粒将药物递送至肾移植物内皮
  • 批准号:
    9164300
  • 财政年份:
    2016
  • 资助金额:
    $ 24.91万
  • 项目类别:
Bioengineered siRNA/Nanoparticles to Prevent Human Transplant Rejection
生物工程 siRNA/纳米颗粒可防止人体移植排斥
  • 批准号:
    8693080
  • 财政年份:
    2013
  • 资助金额:
    $ 24.91万
  • 项目类别:
Controlled Spatiotemporal Delivery of miRNA Anatgomir for Promoting Vascular Self
受控时空递送 miRNA Anatgomir 以促进血管自身
  • 批准号:
    8138278
  • 财政年份:
    2011
  • 资助金额:
    $ 24.91万
  • 项目类别:
SCID Mouse: Human Xenograft Core
SCID 小鼠:人类异种移植核心
  • 批准号:
    7608570
  • 财政年份:
    2008
  • 资助金额:
    $ 24.91万
  • 项目类别:

相似海外基金

Elucidating the molecular basis and expanding the biological applications of the glycosyltransferases using biochemical and structural biology approaches
利用生化和结构生物学方法阐明糖基转移酶的分子基础并扩展其生物学应用
  • 批准号:
    23K14138
  • 财政年份:
    2023
  • 资助金额:
    $ 24.91万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Utilizing the power of synthetic biology and De Novo design for the overexpression and biochemical stabilization of KCNA6 or Kv1.6 potassium channels in the E. coli expression system
利用合成生物学和 De Novo 设计的力量,实现大肠杆菌表达系统中 KCNA6 或 Kv1.6 钾通道的过度表达和生化稳定
  • 批准号:
    10666856
  • 财政年份:
    2023
  • 资助金额:
    $ 24.91万
  • 项目类别:
Developing synthetic chemical biology strategies for biochemical investigations and biomedical applications
开发用于生化研究和生物医学应用的合成化学生物学策略
  • 批准号:
    10623497
  • 财政年份:
    2023
  • 资助金额:
    $ 24.91万
  • 项目类别:
NSF Postdoctoral Fellowship in Biology FY 2022: Defining the biochemical mechanisms of microtubule shrinking and nucleation by combining innovative experiments and simulations
2022 财年 NSF 生物学博士后奖学金:通过结合创新实验和模拟来定义微管收缩和成核的生化机制
  • 批准号:
    2209298
  • 财政年份:
    2022
  • 资助金额:
    $ 24.91万
  • 项目类别:
    Fellowship Award
An Integrated Biochemical and Structural Approach to Delineating the Biology of EWSR1
描述 EWSR1 生物学的综合生化和结构方法
  • 批准号:
    10665058
  • 财政年份:
    2021
  • 资助金额:
    $ 24.91万
  • 项目类别:
An Integrated Biochemical and Structural Approach to Delineating the Biology of EWSR1 - Multi-Mode Detection and Imaging of Biomolecular Condensates.
描述 EWSR1 生物学的综合生化和结构方法 - 生物分子凝聚物的多模式检测和成像。
  • 批准号:
    10797858
  • 财政年份:
    2021
  • 资助金额:
    $ 24.91万
  • 项目类别:
An Integrated Biochemical and Structural Approach to Delineating the Biology of EWSR1
描述 EWSR1 生物学的综合生化和结构方法
  • 批准号:
    10298663
  • 财政年份:
    2021
  • 资助金额:
    $ 24.91万
  • 项目类别:
Physiological and biochemical insights into the biology of marine vertebrates and the ecosystems within which they function
对海洋脊椎动物及其功能的生态系统的生物学的生理和生化见解
  • 批准号:
    RGPIN-2015-04374
  • 财政年份:
    2019
  • 资助金额:
    $ 24.91万
  • 项目类别:
    Discovery Grants Program - Individual
Physiological and biochemical insights into the biology of marine vertebrates and the ecosystems within which they function
对海洋脊椎动物及其功能的生态系统的生物学的生理和生化见解
  • 批准号:
    RGPIN-2015-04374
  • 财政年份:
    2018
  • 资助金额:
    $ 24.91万
  • 项目类别:
    Discovery Grants Program - Individual
Physiological and biochemical insights into the biology of marine vertebrates and the ecosystems within which they function
对海洋脊椎动物及其功能的生态系统的生物学的生理和生化见解
  • 批准号:
    RGPIN-2015-04374
  • 财政年份:
    2017
  • 资助金额:
    $ 24.91万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了